Click a link below to view the mailing archive as if it had been sent to you.
| 2021-09-30 12:15 | | AstraZeneca is nearly ready to seek approval for its COVID-19 antibody. Can it stick the landing? and more... |
| 2021-09-30 00:15 | | Despite rough start, Biogen's Aduhelm should find footing, analysts say. But don't expect much in 2021 and more... |
| 2021-09-29 12:15 | | How Has COVID-19 Changed the Way We Work in the Life Sciences? and more... |
| 2021-09-29 00:15 | | Shionogi licenses out 3rd-gen HIV asset to ViiV, notches a flop in chronic cough and more... |
| 2021-09-28 12:15 | | Behind Epic’s algorithm to detect sepsis before it progresses and more... |
| 2021-09-27 12:15 | | Biogen used charity giving to illegally boost multiple sclerosis drug sales, Humana lawsuit says and more... |
| 2021-09-27 00:15 | | Rumor mill says Acceleron is speeding towards $11bn sale and more... |
| 2021-09-26 00:15 | | Why AbbVie Just Made a $1.8 Billion Gene Therapy Deal and more... |
| 2021-09-25 00:15 | | CDC director overrules advisors on boosters, recommending third shots for at-risk workers and more... |
| 2021-09-24 12:15 | | Merck will pay royalties on next-gen pneumococcal shot to settle Pfizer patent fight and more... |
| 2021-09-24 00:15 | | CDC panel clears way for Pfizer booster shots, but divided on broader use and more... |
| 2021-09-23 12:15 | | AstraZeneca makes RNA play, teaming up with startup to advance twist on red-hot modality and more... |
| 2021-09-23 00:15 | | Do not enter: Biogen reps banned from D.C.-area neurology clinics over controversial Alzheimer's drug Aduhelm and more... |
| 2021-09-22 12:15 | | Pfizer, Moderna, AZ and other COVID vaccine companies face urgent calls to ramp up access around the world and more... |
| 2021-09-22 00:15 | | Edesa finds a signal in severely ill Covid-19 patients and more... |
| 2021-09-21 12:15 | | Johnson & Johnson says additional dose boosts Covid vaccine efficacy and more... |
| 2021-09-21 00:15 | | FDA finalizes more Q&As on biosimilar development and more... |
| 2021-09-20 12:15 | | Exelixis pulls a surprise win in thyroid cancer just days ahead of final Cabometyx readout and more... |
| 2021-09-20 00:15 | | Novartis presents new Kisqali data showing longest median overall survival ever reported in HR+/HER2- advanced breast cancer |
| 2021-09-19 00:15 | | FDA advisers support booster dose of Pfizer vaccine in older or high-risk adults and more... |
| 2021-09-17 12:15 | | ESMO21: Roche’s giredestrant takes stage in battle of the oral SERDs and more... |
| 2021-09-17 00:15 | | FDA approves Eli Lilly antibody cocktail for COVID-19 prevention and more... |
| 2021-09-16 12:15 | | Ahead of FDA adcomm, Pfizer, Moderna say COVID jab efficacy dips and more... |
| 2021-09-16 00:15 | | As Pfizer's booster AdComm nears, FDA staffers say COVID vaccines are already working as intended and more... |
| 2021-09-15 12:15 | | Theravance axing 75% of staff, slashing R&D budget after flunking phase 3 and more... |
| 2021-09-15 00:15 | | Ebola vaccine built on same technology as Covid-19 jab from J&J shows long-lasting success and more... |
| 2021-09-14 12:15 | | Astellas reports fourth death in halted gene therapy trial and more... |
| 2021-09-14 00:15 | | From Pfizer to Argenx: A look at potential blockbusters awaiting FDA decisions this year and more... |
| 2021-09-13 12:15 | | FDA vaccine regulators argue against Covid-19 vaccine boosters in new international review and more... |
| 2021-09-13 00:15 | | Will Pfizer's COVID Vaccine Marketing Push Pay Off? and more... |
| 2021-09-12 00:15 | | Vor's cancer cell therapy gets on FDA fast track ahead of 2022 data drop and more... |
| 2021-09-10 12:15 | | Biden Asks OSHA to Order Vaccine Mandates at Large Employers and more... |
| 2021-09-10 00:15 | | Kaleido warned; FDA not persuaded by 'medical food' claim and more... |
| 2021-09-09 12:15 | | Biogen admits Aduhelm launch ‘slower than we anticipated’ and more... |
| 2021-09-09 00:15 | | Covax will deliver 30% fewer COVID-19 vaccines in 2021 than its goal and more... |
| 2021-09-08 12:15 | | Building a biotech hub: Switzerland puts the focus on personalized medicine, mRNA, CGT and more and more... |
| 2021-09-08 00:15 | | Theranos founder's defense may turn on state of mind, experts say and more... |
| 2021-09-07 12:15 | | The White House wants $65 billion for an ‘Apollo’-style pandemic preparedness program and more... |
| 2021-09-07 00:15 | | Why Medtronic's Latest Quarterly Results Weren't as Good as They Might Seem and more... |
| 2021-09-03 12:15 | | Bristol Myers greenlights neurodegenerative medicine from Evotec pact for $20M and more... |
| 2021-09-03 00:15 | | Former Eli Lilly job applicants say the company's hiring practices favor the young and more... |
| 2021-09-02 12:15 | | FDA approves BeiGene's Brukinsa in rare blood cancer amid company's US expansion plans and more... |
| 2021-09-02 00:15 | | AbbVie's stock and next megablockbuster take hits following new JAK warnings from FDA and more... |
| 2021-09-01 12:15 | | Merck, Amgen adopt double-digit price hikes in test to Big Pharma's unofficial annual limits: analyst and more... |
| 2021-09-01 00:15 | | Clinical trial site remote monitoring may suffice: Updated FDA guidance and more... |
